Montserrat Fraga Christinet

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


72 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 |
2024
 
Gastroentérologie et hépatologie: ce qui a changé en 2023 [Gastroenterology and hepatology: what's new in 2023]
Fraga M., Wakim El-Khoury J., Oumrani S., Godat S., Vionnet J., Schoepfer A., Vieira Barbosa J., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 42-46. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7B220EB3FD8F]
2023
 
An Unusual Cause of Severe Granulomatous Hepatitis and Jaundice.
Coukos A., Uldry E., Meylan S., Schmidt S., Fasquelle F., Sempoux C., Fraga M., 2023/11/01. The American journal of gastroenterology, 118 (11) p. 1920. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E1B8A245AB14]
 
The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening.
Girardet R., Dubois M., Manasseh G., Jreige M., Du Pasquier C., Canniff E., Gulizia M., Bonvin M., Aleman Y., Taouli B. et al., 2023/10. European radiology, 33 (10) pp. 6929-6938. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E8467CFFB8EE]
Elevated liver function tests in a patient with breast cancer.
Neftel C., Zaman K., Chtioui H., Moradpour D., Sempoux C., Fraga M., 2023/09. Journal of hepatology, 79 (3) pp. e109-e111. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E70D878557D9]
 
Hépatologie en 2023 : importance de la multidisciplinarité.
Fraga M., Spahr L., 2023/08/30. Revue medicale suisse, 19 (839) pp. 1535-1536. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7ED0D526DAE8]
Body composition and short-term mortality in patients critically ill with acute-on-chronic liver failure.
Mangana Del Rio T., Sacleux S.C., Vionnet J., Ichaï P., Denys A., Schneider A., Coilly A., Fraga M., Wetzel A., Koerfer J. et al., 2023/08. JHEP reports, 5 (8) p. 100758. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4CE069EB4A31]
The current and future burden of hepatitis B in Switzerland: a modelling study.
Negro F., Müllhaupt B., Semela D., Blach S., Bruggmann P., De Gottardi A., Dufour J.F., Fraga M., Galante A., Razavi H. et al., 2023/06/05. Swiss medical weekly, 153 p. 40086. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0D701EB32CF2]
 
Gastroentérologie et hépatologie : ce qui a changé en 2022 [Gastroenterology and hepatology: what's new in 2022]
Fraga M., Ghaoui C., Stamm G.M., Schoepfer A., Greuter T., 2023/02/01. Revue medicale suisse, 19 (812) pp. 217-220. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_43ED67B9D44E]
Response to a letter to the editor: a better understanding of Immune Checkpoint Inhibitor-induced cholangitis for better management.
Coukos A., Vionnet J., Sempoux C., Fraga M., 2023/02. Journal for immunotherapy of cancer, 11 (2) pp. e006877. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0C82ABD0A663]
Marked weight loss on liraglutide 3.0 mg: Real-life experience of a Swiss cohort with obesity.
Santini S., Vionnet N., Pasquier J., Gonzalez-Rodriguez E., Fraga M., Pitteloud N., Favre L., 2023/01. Obesity, 31 (1) pp. 74-82. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4496D948ED59]
2022
Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events.
Coukos A., Vionnet J., Obeid M., Bouchaab H., Peters S., Latifyan S., Wicky A., Michielin O., Chtioui H., Moradpour D. et al., 2022/10. Journal for immunotherapy of cancer, 10 (10) pp. e005635. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F836C2B098EA]
 
Hepatitis B reactivation during ruxolitinib treatment.
Sjoblom M., Chtioui H., Fraga M., Stalder G., Grandoni F., Blum S., 2022/09. Annals of hematology, 101 (9) pp. 2081-2086. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_97208521780E]
Syndrome des télomères courts chez l’adulte : une entité rare qu’il faut savoir évoquer [Short telomere syndrome in adults: a rare entity that should be evoked]
Coukos A., Daccord C., Lazor R., Blum S., Naveiras O., Unger S., Vionnet J., Gaide O., Koutsokera A., Moschouri E. et al., 2022/08/31. Revue medicale suisse, 18 (793) pp. 1606-1613. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_610156412D48]
Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction.
Artru F., Vietti-Violi N., Sempoux C., Vieira Barbosa J., Becce F., Sah N., Marot A., Deltenre P., Moschouri E., Fraga M. et al., 2022/08. JHEP reports, 4 (8) p. 100511. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7BEB3C21A016]
 
Humoral response to SARS-CoV-2 infection among liver transplant recipients.
Becchetti C., Broekhoven AGC, Dahlqvist G., Fraga M., Zambelli M.F., Ciccarelli O., Saouli A.C., Trizzino A., Banz V., Dufour J.F. et al., 2022/04. Gut, 71 (4) pp. 746-756. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8FC720DDECC5]
Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis.
Kasmi S., Artru F., Barbosa J.V., Deibel A.R., Favre L., Peuble C., Saouli A.C., Goossens N., Müllhaupt B., Pascual M. et al., 2022/02/28. Swiss medical weekly, 152 pp. w30138. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_14011818DC4B]
Iberogast®-Induced Acute Liver Injury—A Case Report
Leroy A., Perrin H., Porret R., Sempoux C., Chtioui H., Fraga M., Bart PA, 2022. Gastro Hep Advances, 1 (4) pp. 601-603.
[URN][DOI][serval:BIB_5E2F0FB82317]
Partial lipodystrophy, severe dyslipidaemia and insulin resistant diabetes as early signs of Werner syndrome.
Atallah I., McCormick D., Good J.M., Barigou M., Fraga M., Sempoux C., Superti-Furga A., Semple R.K., Tran C., 2022. Journal of clinical lipidology, 16 (5) pp. 583-590. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E5FCC361A247]
2021
 
High levels of interleukine-6 in ascites prevent ascites reinfusion during hemodialysis.
Halfon M., Artru F., Fraga M., Comte D., Alberio L., Brunet J.F., Fakhouri F., Kissling S., 2021/09. Clinics and research in hepatology and gastroenterology, 45 (5) p. 101734. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_286BB643A89B]
Hépatite autoimmune : mise au point 2021 [Autoimmune hepatitis: 2021 update]
Stamm G.M., Sempoux C., Fraga M., Comte D., Aubert V., Moradpour D., Vionnet J., Moschouri E., 2021/09/01. Revue medicale suisse, 17 (748) pp. 1457-1463. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E7CF6654AD62]
 
Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy.
Siwicki M., Gort-Freitas N.A., Messemaker M., Bill R., Gungabeesoon J., Engblom C., Zilionis R., Garris C., Gerhard G.M., Kohl A. et al., 2021/07/02. Science immunology, 6 (61) pp. eabi7083. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A24074C576A9]
 
DIPS, a safe and effective alternative in patients with unfavorable anatomy to TIPSS: first experience in a tertiary center.
Moschouri E., Hocquelet A., Vermersch M., Fraga M., Denys A., Artru F., 2021/07. Clinics and research in hepatology and gastroenterology, 45 (4) p. 101715. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3B35877741D5]
 
Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease.
Jordi SBU, Botte F., Lang B.M., Greuter T., Krupka N., Auschra B., Schreiner P., Sulz M.C., Biedermann L., von Känel R. et al., 2021/07. Alimentary pharmacology & therapeutics, 54 (1) pp. 53-67. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_458485CA16A8]
Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue.
Vieira Barbosa J., Müllhaupt B., Brunner F., Filipowicz Sinnreich M., Semela D., Montani M., Cathomas G., Neuweiler J., Gouttenoire J., Artru F. et al., 2021/04/26. Swiss medical weekly, 151 pp. w20502. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EFAEB50E7F8A]
 
Recommandations pour le suivi des patients atteints d'hépatite C guérie
Bobzin Carina, Bsiger Christophe, Bruggmann Philip, Cerny Andreas, Fraga Christinet Montserrat, Keiser Olivia, Knzler-Heule Patrizia, Lavanchy Daniel, Maeschli Bettina, Moradpour Darius et al., 2021/03/16. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_402D0B6700D4]
Gastroentérologie et hépatologie [Advances in gastroenterology and hepatology 2020]
Artru F., Fraga M., Godat S., Schoepfer A.M., Moradpour D., 2021/01/13. Revue medicale suisse, 17 (720-1) pp. 29-32. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_535230AAAD19]
 
Hépatite E: Utilité de la sérologie et de la PCR pour le diagnostic
Psychia Eleni, Fraga Christinet Monserrat, Gouveia Alexandre, 2021/01/05. Forum Médical Suisse ‒ Swiss Medical Forum, 21 (01-02) pp. 22-25.
[DOI][serval:BIB_26D6BAE03D0B]
 
Autoimmune hepatitis as a sequelae of oxcarbazepine-induced drug reaction with eosinophilia and systemic symptoms.
Droz N., Chevrier F., Lapointe A.K., Sempoux C., Fraga M., Comte D., 2021/01. The journal of allergy and clinical immunology. In practice, 9 (1) pp. 580-581. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3F757D73A9EF]
Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Vieira Barbosa J., Sahli R., Aubert V., Chaouch A., Moradpour D., Fraga M., 2021. PloS one, 16 (4) pp. e0250347. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5339E3BF898D]
The histologic presentation of hepatitis E reflects patients' immune status and pre-existing liver condition.
Lenggenhager D., Pawel S., Honcharova-Biletska H., Evert K., Wenzel J.J., Montani M., Furrer E., Fraga M., Moradpour D., Sempoux C. et al., 2021/01. Modern pathology, 34 (1) pp. 233-248. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D4C056334A35]
2020
COVID-19 in an international European liver transplant recipient cohort.
Becchetti C., Zambelli M.F., Pasulo L., Donato M.F., Invernizzi F., Detry O., Dahlqvist G., Ciccarelli O., Morelli M.C., Fraga M. et al., 2020/10. Gut, 69 (10) pp. 1832-1840. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AD0AF3B9E949]
Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.
Fraga M., Moradpour D., Artru F., Romailler E., Tschopp J., Schneider A., Chtioui H., Neerman-Arbez M., Casini A., Alberio L. et al., 2020/10. Journal of hepatology, 73 (4) pp. 967-970. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B2C6A0D6E007]
Early TIPS : une revue pratique après 15 ans d’évidence scientifique [Early TIPS: a practical review after 15 years of scientific evidence]
Shams T., Moschouri E., Denys A., Moradpour D., Fraga M., Artru F., 2020/09/02. Revue medicale suisse, 16 (704) pp. 1548-1553. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_76573276AD15]
Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis.
Zermatten M.G., Fraga M., Calderara D.B., Aliotta A., Moradpour D., Alberio L., 2020/08. JHEP reports, 2 (4) p. 100120. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_07141FDF59B0]
Combined Lung and Liver Transplantation for Short Telomere Syndrome.
Moschouri E., Vionnet J., Giostra E., Daccord C., Lazor R., Sciarra A., Letovanec I., Sempoux C., Gonzalez M., Unger S. et al., 2020/06. Liver transplantation, 26 (6) pp. 840-844. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_67847DD9BC0A]
 
Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis.
Zermatten M.G., Fraga M., Moradpour D., Bertaggia Calderara D., Aliotta A., Stirnimann G., De Gottardi A., Alberio L., 2020/06. Hepatology, 71 (6) pp. 2135-2148. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FE8ABF436E74]
Nouveautés dans la stéatose non alcoolique du foie (NAFLD) [New trends in non-alcoholic fatty liver diseases (NAFLD)]
Barigou M., Favre L., Fraga M., Artru F., 2020/03/25. Revue medicale suisse, 16 (687) pp. 586-591. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8016303EAF6D]
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.
Serra E.G., Schwerd T., Moutsianas L., Cavounidis A., Fachal L., Pandey S., Kammermeier J., Croft N.M., Posovszky C., Rodrigues A. et al., 2020/02/21. Nature communications, 11 (1) p. 995. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_31F78CA4D9D3]
Neurologic complications of acute hepatitis E virus infection.
Ripellino P., Pasi E., Melli G., Staedler C., Fraga M., Moradpour D., Sahli R., Aubert V., Martinetti G., Bihl F. et al., 2020/01. Neurology, 7 (1) pp. e643. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7824310363C5]
2019
 
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.
Martins F., Sofiya L., Sykiotis G.P., Lamine F., Maillard M., Fraga M., Shabafrouz K., Ribi C., Cairoli A., Guex-Crosier Y. et al., 2019/09. Nature reviews. Clinical oncology, 16 (9) pp. 563-580. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7F8DDEE8DA1E]
 
Suivi ambulatoire du patient transplanté hépatique: le rôle essentiel du médecin généraliste [Outpatient follow-up of liver transplant recipients: the essential role of the general practitioner]
Henchoz S., Fraga M., Saouli A.C., Elkrief L., Berney T., Toso C., Compagnon P., Andres A., Denys A., Pascual M. et al., 2019/08/28. Revue medicale suisse, 15 (660) pp. 1488-1495. Peer-reviewed.
[Pmid][serval:BIB_39320710DEE8]
Syndrome d’Alagille [Alagille Syndrome]
Wakim El-Khoury J., Venetz J.P., Rutz T., Sciarra A., Unger S., Sempoux C., Moradpour D., Fraga M., 2019/08/28. Revue medicale suisse, 15 (660) pp. 1506-1510. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_ABC011209ABD]
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report.
Fraga M., Gouttenoire J., Sahli R., Chtioui H., Marcu C., Pascual M., Moradpour D., Vionnet J., 2019/05/24. BMC gastroenterology, 19 (1) p. 76. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_10FD0B1931C2]
 
Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland.
Sahli R., Fraga M., Semela D., Moradpour D., Gouttenoire J., 2019/05. Journal of hepatology, 70 (5) pp. 1023-1025. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FAEA1D95D11D]
 
Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS).
Pittet V., Michetti P., Mueller C., Braegger C.P., von Känel R., Schoepfer A., Macpherson A.J., Rogler G., 2019/04/01. International journal of epidemiology, 48 (2) pp. 385-386f. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_451608A4AF22]
 
Microbial network disturbances in relapsing refractory Crohn's disease.
Yilmaz B., Juillerat P., Øyås O., Ramon C., Bravo F.D., Franc Y., Fournier N., Michetti P., Mueller C., Geuking M. et al., 2019/02. Nature medicine, 25 (2) pp. 323-336. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6158BA54D7F]
The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation.
Tcymbarevich I.V., Eloranta J.J., Rossel J.B., Obialo N., Spalinger M., Cosin-Roger J., Lang S., Kullak-Ublick G.A., Wagner C.A., Scharl M. et al., 2019/01/07. BMC gastroenterology, 19 (1) p. 2. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E3808C2BBE14]
New therapeutic perspectives to manage refractory immune checkpoint-related toxicities.
Martins F., Sykiotis G.P., Maillard M., Fraga M., Ribi C., Kuntzer T., Michielin O., Peters S., Coukos G., Spertini F. et al., 2019/01. The Lancet. Oncology, 20 (1) pp. e54-e64. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_42DB9145A8A7]
2018
Hepatic manifestations of Wilson's disease: 12-year experience in a Swiss tertiary referral centre.
Vieira Barbosa J., Fraga M., Saldarriaga J., Hiroz P., Giostra E., Sempoux C., Ferenci P., Moradpour D., 2018/12/17. Swiss medical weekly, 148 pp. w14699. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CDB29876DD5D]
Cholangite biliaire primitive : mise à jour [Primary biliary cholangitis : an update]
Vieira Barbosa J., Vionnet J., Sciarra A., Sempoux C., Aubert V., Moradpour D., Fraga Christinet M., 2018/08/29. Revue medicale suisse, 14 (616) pp. 1489-1494. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B0081B423DB4]
 
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort.
Madanchi M., Fagagnini S., Fournier N., Biedermann L., Zeitz J., Battegay E., Zimmerli L., Vavricka S.R., Rogler G., Scharl M. et al., 2018/07/12. Inflammatory bowel diseases, 24 (8) pp. 1768-1779. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9C0BC1704FAB]
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.
Godat S., Fournier N., Safroneeva E., Juillerat P., Nydegger A., Straumann A., Vavricka S., Biedermann L., Greuter T., Fraga M. et al., 2018/06. European journal of gastroenterology & hepatology, 30 (6) pp. 612-620. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F31099178815]
 
Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland.
Fraga M., Doerig C., Moulin H., Bihl F., Brunner F., Müllhaupt B., Ripellino P., Semela D., Stickel F., Terziroli Beretta-Piccoli B. et al., 2018/04. Liver international, 38 (4) pp. 619-626. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_989825B85C8C]
Prurit-disciplinaire
Schneider Alexandra, Moschouri Eleni, Fraga Christinet Montserrat, Sciarra Amedeo, Sempoux Christine, Papadakis Georgios, Sykiotis Gerasimos, Sartori Claudio, Duss François-Regis, 2018/02/14. Forum Médical Suisse ‒ Swiss Medical Forum, 18 (07).
[URN][DOI][serval:BIB_E642FABE26C4]
 
Heterotopic Gastric Mucosa in a Duplication Cyst of the Common Hepatic Duct Mimicking Cholangiocarcinoma.
Sciarra A., Hessler R., Godat S., Fraga M., Dromain C., Duran R., Halkic N., Sempoux C., 2018/02. International journal of surgical pathology, 26 (1) pp. 84-88. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0171DFAFBED0]
Rapid Remission of Graves' Hyperthyroidism Without Thionamides Under Immunosuppressive Treatment for Concomitant Autoimmune Hepatitis.
Papadakis G.E., Lamine F., Chtioui H., Moschouri E., Christinet M.F., Marino L., Favre L., Sciarra A., Sempoux C., Schneider A. et al., 2018/02. Thyroid, 28 (2) pp. 276-278. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9AD89D587A49]
 
Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease.
Lang B.M., Biedermann L., van Haaften W.T., de Vallière C., Schuurmans M., Begré S., Zeitz J., Scharl M., Turina M., Greuter T. et al., 2018/01. Alimentary pharmacology & therapeutics, 47 (1) pp. 55-66. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AA99F97912AB]
2017
 
Visualization of hepatitis E virus RNA and proteins in the human liver.
Lenggenhager D., Gouttenoire J., Malehmir M., Bawohl M., Honcharova-Biletska H., Kreutzer S., Semela D., Neuweiler J., Hürlimann S., Aepli P. et al., 2017/09. Journal of hepatology, 67 (3) pp. 471-479. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EFFF1ED90897]
 
Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy.
van Eijk JJJ, Dalton H.R., Ripellino P., Madden R.G., Jones C., Fritz M., Gobbi C., Melli G., Pasi E., Herrod J. et al., 2017/08/29. Neurology, 89 (9) pp. 909-917. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C9B115AF8AF3]
 
Akute und chronische Hepatitis E []
Fraga M., Gouttenoire J., Sahli R., Moradpour D., 2017/07. Therapeutische Umschau. Revue therapeutique, 74 (3) pp. 109-113. Peer-reviewed.
[DOI][Pmid][serval:BIB_007DA0AD1C32]
 
Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
Fraga M., Fournier N., Safroneeva E., Pittet V., Godat S., Straumann A., Nydegger A., Vavricka S.R., Moradpour D., Schoepfer A.M. et al., 2017/01. European journal of gastroenterology & hepatology, 29 (1) pp. 91-97. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_30CE534E379D]
2016
Traitement curatif du cancer de l'oesophage: consensus multidisciplinaire multicentrique [Curative treatment for esophageal cancer: results of a multidisciplinary consensus]
Allemann P., Mantziari S., Wagner D., Digklia A., Ozsahin E., De Bari B., Dorta G., Godat S., Montserrat F., Sempoux C. et al., 2016/06/15. Revue medicale suisse, 12 (523) pp. 1165-1169. Peer-reviewed.
[URN][Pmid][serval:BIB_58E6531A0AFA]
 
Hepatitis E
Béguelin Charles, Fraga Montserrat, Wandeler Gilles, Sahli Roland, Rauch Andri, Moradpour Darius, 2016/06/14. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, 16 (24) pp. 510-514. Peer-reviewed.
[DOI][serval:BIB_4632ABFAFF1C]
 
Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease.
Mikocka-Walus A., Pittet V., Rossel J.B., von Känel R., Swiss IBD Cohort Study Group, 2016/06. Clinical gastroenterology and hepatology, 14 (6) pp. 829-835.e1. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5A17200302BF]
 
Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way?
Mueller R., Ziade F., Pittet V., Fournier N., Ezri J., Schoepfer A., Schibli S., Spalinger J., Braegger C., Nydegger A. et al., 2016. Journal of Crohn's and Colitis, 10 (3) pp. 269-276. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3DA6ADEBDF1E]
2015
 
Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials.
Deltenre P., Trépo E., Rudler M., Monescillo A., Fraga M., Denys A., Doerig C., Fournier N., Moreno C., Moradpour D. et al., 2015. European Journal of Gastroenterology and Hepatology, 27 (9) pp. e1-e9. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5F53DAF17F73]
 
Risques et bénéfices d'une approche interventionnelle face aux corps étrangers digestifs [Digestive foreign body management].
Fraga M., Nydegger A., Abdelrahman K., Burgmann K., Maillard M.H., Dorta G., 2015. Revue Médicale Suisse, 11 (484) pp. 1592-1595.
[Pmid][serval:BIB_2720C03918CF]
2014
 
Actualités en gastroentérologie et hépatologie [Highlights in gastroenterology and hepatology 2013].
Hessler R., Godat S., Fraga M., Burgmann K., Doerig C., Deltenre P., Schoepfer A., 2014. Revue Médicale Suisse, 10 (412-413) pp. 41-44.
[Pmid][serval:BIB_BD436C1B869B]
 
Colites microscopiques--quoi de neuf ? [Microscopic colitis: update 2014].
Burgmann K., Fraga M., Schoepfer A.M., Yun P., 2014. Revue Médicale Suisse, 10 (440) pp. 1586, 1588-1586, 1590.
[Pmid][serval:BIB_91F16A0CB5D6]
2013
 
Traitement par radiofréquence de l'oesophage de Barrett [Radiofrequency ablation for Barret's esophagus].
Fraga M., Doerig C., Dorta G., Nichita C., 2013. Revue Médicale Suisse, 9 (396) pp. 1572-1576.
[Pmid][serval:BIB_F3962277338C]
2012
 
Calprotectine fécale: outil diagnostique dans les maladies inflammatoires chroniques de l'intestin [Fecal calprotectin: a diagnostic tool for inflammatory bowel disease].
Fraga M., Godat S., Nydegger A., Moradpour D., Schoepfer A.M., 2012. Revue Médicale Suisse, 8 (352) pp. 1669-1673.
[Pmid][serval:BIB_ABFD159F9977]
2010
 
The inter-rater reliability of the Pulmonary Embolism Severity Index.
Fraga M., Taffé P., Méan M., Hugli O., Witzig S., Waeber G., Aujesky D., 2010. Thrombosis and Haemostasis, 104 (6) pp. 1258-1262.
[DOI][WoS][Pmid][serval:BIB_2AF12AEE9384]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University